Bio-Techne Corp (TECH) to Issue Quarterly Dividend of $0.08 on May 29th

Bio-Techne Corp (NASDAQ:TECH) announced a quarterly dividend on Wednesday, May 6th. Stockholders of record on Monday, May 18th will be given a dividend of 0.08 per share by the biotechnology company on Friday, May 29th. This represents a c) annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, May 18th.

Bio-Techne has a dividend payout ratio of 15.4% indicating that its dividend is sufficiently covered by earnings. Analysts expect Bio-Techne to earn $1.90 per share next year, which means the company should continue to be able to cover its $0.32 annual dividend with an expected future payout ratio of 16.8%.

Bio-Techne Price Performance

NASDAQ:TECH opened at $50.91 on Friday. Bio-Techne has a 52 week low of $45.12 and a 52 week high of $72.16. The company has a quick ratio of 3.08, a current ratio of 4.49 and a debt-to-equity ratio of 0.10. The company has a market capitalization of $7.97 billion, a P/E ratio of 73.78, a P/E/G ratio of 3.12 and a beta of 1.41. The stock’s fifty day moving average is $54.41 and its two-hundred day moving average is $59.54.

Bio-Techne (NASDAQ:TECH) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $0.53 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.02). Bio-Techne had a net margin of 9.05% and a return on equity of 13.57%. The business had revenue of $311.42 million during the quarter, compared to analysts’ expectations of $316.11 million. During the same quarter in the prior year, the firm earned $0.56 EPS. Bio-Techne’s revenue for the quarter was down 1.5% compared to the same quarter last year. Equities analysts expect that Bio-Techne will post 1.73 EPS for the current year.

About Bio-Techne

Bio-Techne Corporation (NASDAQ:TECH) is a global life sciences company that develops, manufactures and sells high-quality reagents, instruments and services for the research, diagnostic and bioprocessing markets. Its core product offerings include recombinant proteins, antibodies, immunoassays, nucleic acid probes and kits, single-cell analysis solutions and automated protein analysis systems. Flagship brands such as R&D Systems, Novus Biologicals, ProteinSimple and Advanced Cell Diagnostics provide researchers and clinicians with reliable tools for cell biology, immunology, proteomics and genomics applications.

Headquartered in Minneapolis, Minnesota, Bio-Techne serves customers across North America, Europe and the Asia-Pacific region through a combination of direct sales, distributors and strategic partnerships.